SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-175113
Filing Date
2024-07-03
Accepted
2024-07-03 17:19:30
Documents
13
Period of Report
2024-07-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d796654d8k.htm   iXBRL 8-K 24857
  Complete submission text file 0001193125-24-175113.txt   147117

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bolt-20240702.xsd EX-101.SCH 2837
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bolt-20240702_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bolt-20240702_pre.xml EX-101.PRE 11249
15 EXTRACTED XBRL INSTANCE DOCUMENT d796654d8k_htm.xml XML 3640
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 241100948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)